NIA commentary: Translational issues in alzheimers disease drug development

Neuropsychopharmacology

Volumn 37, Issue 1, 2012, Pages 284-286

  Buckholtz, Neil S ^a   Ryan, Laurie M ^a   Petanceska, Suzana ^a   Refolo, Lorenzo M ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARVEDILOL; INSULIN;

AGING; ALZHEIMER DISEASE; CLINICAL TRIAL (TOPIC); COGNITIVE DEFECT; DRUG DEVELOPMENT; DRUG INDUSTRY; HUMAN; NONHUMAN; NOTE; PRIORITY JOURNAL; PUBLIC-PRIVATE PARTNERSHIP; SYSTEMS BIOLOGY; TRANSLATIONAL RESEARCH;

AGED; ALZHEIMER DISEASE; ANIMALS; DRUG DESIGN; HUMANS; NATIONAL INSTITUTE ON AGING (U.S.); NEUROPHARMACOLOGY; TRANSLATIONAL MEDICAL RESEARCH; UNITED STATES;

EID: 84856104506     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2011.116     Document Type: Note

References (7)

1. Ashe KH, Zahs KR (2010). Probing the biology of Alzheimer's disease in mice. Neuron 66: 631-645.
2. Burton A (2011). Big science for a big problem: ADNI enters its second phase. Lancet Neurol 10: 206-207.
3. Cressey D (2011). Traditional drug-discovery model ripe for reform. Nature 471: 17-18.
4. Liu Z-P, Wang Y, Zhang X-S, Chen L (2010). Identifying dysfunctional crosstalk of pathways in various regions of Alzheimer's disease brains. BMC Syst Biol 4(Supp2): S11.
5. Sena ES, van der Worp HB, Bath PMW, Howells DW, Macleod MR (2010). Publication bias in reports of animal stroke studies leads to major overstatement of efficacy. PLoS Biol 8: e1000344.
6. Van der Worp HB, Howells DW, Sena ES, Porritt MJ, Rewell S, O'Collins V et al (2010). Can animal models of disease reliably inform human studies? PLoS Med 7: e100245.
7. Zahs KR, Ashe KH (2010). 'Too much good news'-are Alzheimer mouse models trying to tell us how to prevent, not cure, Alzheimer's disease? Trends Neurosci 33: 381-389.